You are here:
Home
NICE Guidance
Conditions and diseases
Digestive tract conditions
Inflammatory bowel disease
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]
Topic selection
Project information
Project documents
On this page
Topic selection
Topic selection
Documents
Documents created during the development process.
Topic selection
Topic selection
Topic selection
Topic selection
Back to top